When combined with increased physical activity and a low-calorie diet, semaglutide (Wegovy) is indicated for weight management in patients with: Obesity (BMI of 30 kg/m or higher) Overweight (BMI of 27 kg/m or higher) with at least one weight-related health condition such as high cholesterol levels, hypertension (high blood pressure), heart disease, and type 2 diabetes Mechanism of action Semaglutide is a GLP-1 agonist that slows digestion, reduces appetite, and stabilizes blood sugar by working in the following ways: It mimics the action of glucagon-like peptide-1 in the lateral hypothalamus (hunger control centre), which suppresses appetite and gives you a feeling of satiety
In a landmark Phase 2 trial, patients receiving the highest dose of retatrutide (12 mg) achieved an average weight loss of 24.2% after 48 weeks
What is Tirzepatide, and how does it aid in weight loss
Vitamin E and grapeseed extract help support overall wellness and skin vitality
Gastrointestinal motility disorders in neurologic disease
So which option is right for you